2/2
08:00 am
apm
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
High
Report
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
12/17
04:32 pm
apm
Aptorum Group (NASDAQ:APM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Aptorum Group (NASDAQ:APM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/5
04:14 pm
apm
Aptorum Group (NASDAQ:APM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Aptorum Group (NASDAQ:APM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.